In contrast, HLA-G expression on TILs was not linked to a decrease in survival rates, suggesting that it is HLA-G expression on tumour cells, rather than on TILs, that orchestrates biological behavior of MIBC and thus HLA-G’s impact on clinical outcomes. This evidence concerns the gene HLA-G and neoplasm.